SSWM
Sheets Smith Wealth Management’s TransCode Therapeutics RNAZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50,138
| Closed | -$28.6K | – | 395 |
|
|
2024
Q3 | $28.6K | Buy |
50,138
+30,000
| +149% | +$17.1K | ﹤0.01% | 371 |
|
|
2024
Q2 | $20.2K | Buy |
+20,138
| New | +$20.2K | ﹤0.01% | 373 |
|
|
2023
Q2 | – | Sell |
-60,000
| Closed | -$20.3K | – | 341 |
|
|
2023
Q1 | $20.3K | Buy |
60,000
+35,000
| +140% | +$11.8K | ﹤0.01% | 314 |
|
|
2022
Q4 | $16.8K | Buy |
+25,000
| New | +$16.8K | ﹤0.01% | 308 |
|